EAPH Stock | News | Quote | Stock Forum | Wednesday, November

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$EAPH Easton Pharmaceuticals, Inc. EAPH Company Overview 

Easton Pharmaceuticals, Inc. EAPH Current Price and Quotes
Last Price 0.0053
Previous Close 0.0025 Open 0.003
Daily Range 0.007 - 0.0023 52wk Range 0.028 - 0.0014
Volume 51,302,373 Dividend N/A
Average Vol (3m) 6,846,155 Yield N/A

EAPH Stock Message Board http://investorshangout.com/search?q=EAPH&...mp;yt1=Go!

Last Updated: Wednesday, November 6, 2013 5:54:21 PM

Easton Pharmaceuticals, Inc. EAPH
Company Information

425 University Ave
Suite 500
Toronto, ONT M5G1T6
Canada

Website: http://www.lamindustries.com
Phone: 416-619-0291
Email: info@lamindustries.com

Easton Pharmaceuticals, Inc. EAPH
Drug / OTC Research and Development

Easton Pharmaceuticals, Inc. EAPH
Financial Reportings and Disclosures

Reporting Status Alternative Reporting Standard
Deregistered a/o Jan 29, 2009
Audited Financials Unaudited
Latest Report Jun 30, 2013 Quarterly Report
CIK 0001071272
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o May 05, 1998
Incorporated In: WY, USA
Year of Inc. 1998
Employees 4 a/o Nov 27, 2012
Company Officers/Contacts

Walter Folinski CEO, President
John Adams CEO
Company Directors

Not Available
Company Notes

Formerly=LAM Industries Inc. until 3-2010
Formerly=L.A.M. Pharmaceutical Corp. until 4-2009
Service Providers

Auditor/Accountant
KBL, LLP
110 Wall Street
11th Floor
New York, NY, 10005
United States

Mehra & Associates
Palm Beach, FL, United States

Legal Counsel
William F. Doran
1717 East Bell Road
Phoenix, AZ, 85022
United States

Wilson & Oskam LLP
9110 Irvine Center Drive
Irvine, CA, 92618
United States

Investor Relations Firm
Not Available

Easton Pharmaceuticals, Inc. EAPH
EAPH Security Details

Share Structure

Market Value1 $319,533 a/o Nov 05, 2013
Shares Outstanding 127,813,017 a/o May 05, 2013
Float 62,811,618 a/o May 05, 2013
Authorized Shares 250,000,000 a/o Aug 02, 2013
Par Value  0.0001
Shareholders

Shareholders of Record 198 a/o May 05, 2013
Security Notes

Capital Change=shs decreased by 1 for 3000 split. Pay date=04/30/2009.
Short Selling Data

Short Interest 0 (-100%)
Oct 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Corporate Stock Transfer, Inc.

Easton Pharmaceuticals, Inc. EAPH Financials
Period Ending Dec 31, 2012 Dec 31, 2011
Total Revenue - -
Cost of Revenue - -
Gross Profit - -
Operating Expenses

Research and Development 68 6
Sales, General and Admin. 115 107
Non-Recurring Items - -
Other - -
Operating Income (183) (113)
Income From Continuing Operations

Add'l Income/Expense Items - -
Earnings Before Interest and Tax (183) (113)
Interest Expense - -
Earnings Before Tax (183) (113)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (183) (113)
Non Recurring Events

Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (183) (113)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (183) (113)

Easton Pharmaceuticals, Inc. EAPH Recent News

Nov 6, 2013 Easton Pharmaceuticals Enters Into Cancer Drug Industry by Acquiring Initial Minority Ownership Interest in Experimental Cancer Drug "XILIVE" With 12 Month Option to Purchase Remaining Interest; Preliminary Feedback Extremely Promising
Nov 6, 2013 Gary Simpson of Windmill Capital s Ivy Family Office Network Boston Forum
Nov 4, 2013 Easton Pharmaceuticals Is Provided a Manufacturing, Regulatory Filing Update and Forward Sales Estimates for VIORRA
Oct 22, 2013 Easton Pharmaceuticals Announces Formal Agreement & Advances Payment to BMV Medica S.A. Towards a Regulatory Filing in Mexico for "Viorra"; Company Anticipates Approval and Initial Sales by End of Second Quarter 2014
Oct 4, 2013 Easton Pharmaceuticals Announces Application to Obtain a Distributorship License Towards Its Canadian Medical Marijuana Initiatives
Sep 27, 2013 Easton Pharmaceuticals Signs LOI to Acquire a Cosmetic Anti-Aging and Beauty Care Line of Products Including a Product to Compliment its Medical Marijuana Initiatives
Sep 16, 2013 Easton Pharmaceuticals Re- Enters Drug Market, Acquires 50% Ownership Interest In FSAD Drug And Related Patents / Patent Pendings. Drug Subsequently Underwent Clinical Trials At Cedar-Sinai Medical Center, Beverley Hills, CA.
Aug 23, 2013 Easton Pharmaceuticals, Inc. Provides Update on Its Medical Marijuana Initiatives
Aug 14, 2013 Easton Pharmaceuticals Announces It Has Ordered Ingredients towards Producing Final Test and Trial Samples of Its Re-Formulated Viorra and Other Recently Added Portfolio Products


EAPH Easton Pharmaceuticals, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=EAPH&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/EAPH/quote
Stock Chart http://www.otcmarkets.com/stock/EAPH/chart
Company Info http://www.otcmarkets.com/stock/EAPH/company-info
Recent News http://www.otcmarkets.com/stock/EAPH/news
Financials http://www.otcmarkets.com/stock/EAPH/financials
Filings and Disclosure http://www.otcmarkets.com/stock/EAPH/filings
Short Sales http://www.otcmarkets.com/stock/EAPH/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/EAPH/insider-transactions
Research Reports http://www.otcmarkets.com/stock/EAPH/research
Summary http://finance.yahoo.com/q?s=EAPH
Historical Prices http://finance.yahoo.com/q/hp?s=EAPH+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=EAPH
Basic Chart http://finance.yahoo.com/q/bc?s=EAPH+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=EAPH+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=EAPH+Headlines
Press Releases http://finance.yahoo.com/q/p?s=EAPH+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=EAPH+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=EAPH+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=EAPH+Industry
Major Holders http://finance.yahoo.com/q/mh?s=EAPH+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=EAPH+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=EAPH+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=EAPH
Balance Sheet http://finance.yahoo.com/q/bs?s=EAPH
Cash Flow http://finance.yahoo.com/q/cf?s=EAPH+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/EAPH
Market Watch http://www.marketwatch.com/investing/stock/EAPH
Bloomberg http://www.bloomberg.com/quote/EAPH:US
Morningstar http://quotes.morningstar.com/stock/s?t=EAPH
Bussinessweek http://investing.businessweek.com/research/st...icker=EAPH
Barchart http://www.barchart.com/quotes/stocks/EAPH
OTC Short Report http://otcshortreport.com/index.php?index=EAPH
Investopedia http://www.investopedia.com/markets/stocks/EAPH/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

iBio's Fiscal Year 2024: Innovations and Financial Insights

Updated Category News Views 108

Overview of iBio’s Fiscal Year 2024 Financial Results iBio, Inc. (NYSEA:IBIO), a leader in biopharmaceuticals using AI technology, has recently shared its financial performance for the fiscal year that ended on June 30, 2024. The company is dedicated to developing antibody therapies for complex conditions, utilizing machine learning approaches to enhance their efforts....

Continue Reading
Atossa Therapeutics Ready to Present (Z)-Endoxifen Data Soon

Updated Category News Views 129

Exciting Developments for Atossa Therapeutics at Upcoming Symposium SEATTLE, November 2024 – Atossa Therapeutics, Inc. (NASDAQ: ATOS), a biopharmaceutical company known for its innovative approach in treating breast cancer, is gearing up to share groundbreaking research on (Z)-endoxifen at the upcoming San Antonio Breast Cancer Symposium (SABCS). This symposium is an...

Continue Reading
DraftKings Sportsbook Set to Debut at Live! Casino & Hotel

Updated Category News Views 100

Exciting Announcement for Sports Fans at Live! Casino & Hotel DraftKings is thrilled to announce its role as the official sportsbook for the highly anticipated Live! Casino & Hotel, which boasts a remarkable investment of over $270 million. This venue is set to create waves in the sports entertainment scene. The grand opening is expected, and it promises to be a game...

Continue Reading
Transforming Learning Spaces: A Milestone Celebration Ahead

Updated Category News Views 233

Transforming Learning Spaces with Collaborative Efforts In a remarkable initiative, School Specialty and the College Football Playoff Foundation are making strides in enhancing the educational landscape. Their recent accomplishment includes the makeover of a media center at North Dade Middle School, marking the 100th transformed learning environment as part of the Extra...

Continue Reading
Velvet Taco Innovates Menu with Exciting New Velvet Bowls

Updated Category News Views 481

Velvet Taco Introduces New Velvet Bowls to Excite Diners In an exciting move to shake up its menu, Velvet Taco proudly announces the launch of its latest creation, the Velvet Bowls. This fresh offering arrives after a successful "Weekly Bowl Feature" campaign that highlighted the restaurant's adventurous flavors without the need for tortillas. As a taco restaurant renown...

Continue Reading